The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 31, 2020
Filed:
Oct. 02, 2017
Applicant:
Mati Therapeutics Inc., Austin, TX (US);
Inventors:
Assignee:
Mati Therapeutics Inc., Austin, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 9/00 (2006.01); A61K 31/165 (2006.01); A61K 31/569 (2006.01); A61K 38/13 (2006.01); A61K 47/10 (2017.01); A61K 9/00 (2006.01); A61K 47/34 (2017.01); A61K 9/14 (2006.01); A61F 9/007 (2006.01); A61K 31/573 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0051 (2013.01); A61F 9/0017 (2013.01); A61F 9/00772 (2013.01); A61K 9/146 (2013.01); A61K 31/165 (2013.01); A61K 31/569 (2013.01); A61K 31/573 (2013.01); A61K 38/13 (2013.01); A61K 47/10 (2013.01); A61K 47/34 (2013.01);
Abstract
A solid matrix sustained release ophthalmic formulation for topical delivery of a solid ophthalmic drug to the eye, medical devices, drug cores, drug inserts and drug delivery systems comprising the formulation, methods of manufacturing the formulation, medical devices and their methods thereof for delivering the ophthalmic drug for a treatment period provided herein. The formulation disclosed herein is an admixture of an ophthalmic drug, and a combination of a hydrophobic polymer, a hydrophilic polymer and a surfactant, wherein the drug is eluted daily over an extended period of time at therapeutic dose of drug.